Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin

BACKGROUND: Inflammation contributes to the pathophysiology of major depressive disorder (MDD), and anti-inflammatory strategies might therefore have therapeutic potential. This trial aimed to determine whether adjunctive aspirin or rosuvastatin, compared with placebo, reduced depressive symptoms in...

Descripción completa

Detalles Bibliográficos
Autores principales: Berk, Michael, Mohebbi, Mohammadreza, Dean, Olivia M., Cotton, Sue M., Chanen, Andrew M., Dodd, Seetal, Ratheesh, Aswin, Amminger, G. Paul, Phelan, Mark, Weller, Amber, Mackinnon, Andrew, Giorlando, Francesco, Baird, Shelley, Incerti, Lisa, Brodie, Rachel E., Ferguson, Natalie O., Rice, Simon, Schäfer, Miriam R., Mullen, Edward, Hetrick, Sarah, Kerr, Melissa, Harrigan, Susy M., Quinn, Amelia L., Mazza, Catherine, McGorry, Patrick, Davey, Christopher G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966789/
https://www.ncbi.nlm.nih.gov/pubmed/31948461
http://dx.doi.org/10.1186/s12916-019-1475-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966789/
https://www.ncbi.nlm.nih.gov/pubmed/31948461
http://dx.doi.org/10.1186/s12916-019-1475-6

Ejemplares similares